Table 3.
Received an independent research award?a | Odds ratiob |
95% confidence interval |
||||
---|---|---|---|---|---|---|
No | Yes | |||||
Characteristic | no. | % | no. | % | ||
Clinical and PhD trainingc | ||||||
Clinician, no PhD | 233 | 65.4 | 106 | 56.4 | 1 | ref |
Clinician with PhD | 76 | 21.3 | 47 | 25.0 | 1.17 | 0.69 – 1.96 |
Non-clinician PhD | 47 | 13.2 | 35 | 18.6 | 2.05 | 1.11 – 3.78 |
Pursued MS or PhD during KL2 training | ||||||
No | 198 | 55.9 | 127 | 67.6 | 1 | ref |
Yes | 156 | 44.1 | 61 | 32.4 | 0.83 | 0.49 – 1.41 |
Sex | ||||||
Male | 165 | 46.2 | 91 | 47.9 | 1 | ref |
Female | 192 | 53.8 | 99 | 52.1 | 0.87 | 0.57 – 1.31 |
URM statusd | ||||||
Not URM | 305 | 86.2 | 167 | 90.8 | 1 | ref |
URM | 49 | 13.8 | 17 | 9.2 | 0.81 | 0.42 – 1.58 |
When completed KL2 training | ||||||
Within the last 2 years | 131 | 36.8 | 40 | 21.2 | 1 | ref |
2–3 years earlier | 127 | 35.7 | 91 | 48.2 | 2.47 | 1.46 – 4.16 |
4+ years earlier | 98 | 27.5 | 58 | 30.7 | 2.51 | 1.40 – 4.51 |
Defined as the principal investigator (PI) of a National Institutes of Health (NIH) R01 award, PI of a project within an NIH program project or right award (e.g., P01), or PI of an independent, externally-funded, non-NIH, peer-reviewed research project of 3 or more years duration. Does not include mentored research awardsor industry-funded trials.
Odds ratios are from a mixed effects regression analysis, which treated the institution as a random effect and included all variables listed in this table as covariates.
Defined as training prior to appointment as a KL2 scholar.
Underrepresented in medicine (URM) includes Black or African American, American Indian or Alaska Native, Native Hawaiianor Pacific Islander, and Hispanic or Latino.